Avient
AVNT · Specialty Chemicals
$41.03
1.1%Solstice Advanced Materials
SOLS · Specialty Chemicals
$59.42
0.6%The short version
- Solstice Advanced Materials is the larger business, with $3.9B of revenue in fiscal 2025 against $3.3B for Avient.
- Solstice Advanced Materials grew revenue faster (3.1%, against 0.6%).
- Avient turned more of its sales into free cash flow (6.0% FCF margin, against 3.1% FCF margin).
- Solstice Advanced Materials earned a higher return on the capital invested in it (12.2%, against 4.0%).
- Investors pay more for each dollar of Solstice Advanced Materials’s earnings: a P/E of 39.9x against 22.2x for Avient.
| Latest fiscal year | AVNT · FY25 | SOLS · FY25 |
|---|---|---|
| Size | ||
| Market cap | $3.8B | $9.5B |
| Revenue | $3.3B | $3.9B |
| Free cash flow | $195M | $119M |
| Net income | $81.9M | $237M |
| Growth | ||
| Revenue growth | 0.6% | 3.1% |
| 5-year growth | 8.0% | — |
| Share count change | −0.2% | 0.1% |
| Profitability | ||
| Gross margin | 31.2% | 32.2% |
| Operating margin | 6.2% | — |
| Net margin | 2.5% | 6.1% |
| FCF margin | 6.0% | 3.1% |
| Return on capital | 4.0% | 12.2% |
| Return on equity | 3.5% | 10.2% |
| Balance sheet | ||
| Net debt | $1.4B | $1.6B |
| Net debt / EBITDA | 3.6x | 2.3x |
| Dividends and buybacks | $98.8M | $1.5B |
| Valuation & quality | ||
| P/E | 22.2x | 39.9x |
| Piotroski F-score | 6 | — |
FY16
AVNT $2.9B
SOLS —
FY17
AVNT $2.6B
SOLS —
FY18
AVNT $2.9B
SOLS —
FY19
AVNT $2.9B
SOLS —
FY20
AVNT $2.2B
SOLS —
FY21
AVNT $3.3B
SOLS —
FY22
AVNT $3.4B
SOLS —
FY23
AVNT $3.1B
SOLS $3.6B
FY24
AVNT $3.2B
SOLS $3.8B
FY25
AVNT $3.3B
SOLS $3.9B
AVNT
SOLS
FY16
AVNT 9.1%
SOLS —
FY17
AVNT 6.7%
SOLS —
FY18
AVNT 6.2%
SOLS —
FY19
AVNT 5.5%
SOLS —
FY20
AVNT 5.0%
SOLS —
FY21
AVNT 8.4%
SOLS —
FY22
AVNT 7.2%
SOLS —
FY23
AVNT 6.3%
SOLS —
FY24
AVNT 10.2%
SOLS —
FY25
AVNT 6.2%
SOLS —
AVNT
SOLS
FY16
AVNT $143M
SOLS —
FY17
AVNT $123M
SOLS —
FY18
AVNT $178M
SOLS —
FY19
AVNT $219M
SOLS —
FY20
AVNT $158M
SOLS —
FY21
AVNT $133M
SOLS —
FY22
AVNT $293M
SOLS —
FY23
AVNT $82.2M
SOLS $461M
FY24
AVNT $135M
SOLS $546M
FY25
AVNT $195M
SOLS $119M
AVNT
SOLS
FY16
AVNT 11.8%
SOLS —
FY17
AVNT 10.1%
SOLS —
FY18
AVNT 9.1%
SOLS —
FY19
AVNT 6.9%
SOLS —
FY20
AVNT 5.1%
SOLS —
FY21
AVNT 7.0%
SOLS —
FY22
AVNT 7.0%
SOLS —
FY23
AVNT 4.4%
SOLS —
FY24
AVNT 6.5%
SOLS —
FY25
AVNT 4.0%
SOLS 12.2%
AVNT
SOLS
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.